Lexeo Therapeutics LXEO
NASDAQ LXEO
$3.38 -0.04 (-1.17%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lexeo Therapeutics (LXEO) Other financing activities (2023)

Updated

Lexeo Therapeutics (LXEO) reported Other financing activities of $75,000 for Q4 2023.

Analysis

Lexeo Therapeutics (LXEO) Other financing activities (2023) Analysis & Trends

For FY2023, Lexeo Therapeutics posted Other financing activities of $86,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lexeo Therapeutics 265.74 Mn 265.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 75,000.00
API Access

Lexeo Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=LXEO&period=max&api_key=YOUR_API_KEY